Overview
Terri Parker is a Hematologist Oncology specialist and a Hematologist in New Haven, Connecticut. Dr. Parker is rated as an Advanced provider by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). Her top areas of expertise are Monoclonal Gammopathy of Undetermined Significance (MGUS), Multiple Myeloma, Schnitzler Syndrome, Smoldering Multiple Myeloma, and Bone Marrow Aspiration.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
800 Howard Ave, New Haven, CT 06519
20 York St, New Haven, CT 06510
6 Devine St, North Haven, CT 06473
Northwell Health Center For Advanced Medicine, RJ Zuckerberg Cancer Center
The Chronic Lymphocytic Leukemia (CLL) Research and Treatment Program has become a landmark for CLL patients worldwide. Dr. Kanti Rai has been involved in diagnosing and treating CLL for almost 40 years and the staging system that bears his name came out of his early breakthrough research. His particular areas of interest are: natural history of CLL, improving prognostic features of this disease and developing newer strategies of therapy which are hypothesis-driven. Dr. Rai is an active member of the International Workshop on CLL (iwCLL) and Dr. Keating s Global CLL Foundation. He is an active member of the American Society of Clinical Oncology (ASCO), American Association for Cancer Research (AACR) and the American Society of Hematology (ASH). In 2006, Dr. Rai served as the President of ASH. He was the recipient of ASCO s David Karnofsky Memorial Award in 2012. In 2013, Dr. Rai was honored with the iwCLL David Galton award. In 2014 he was presented with ASH s Wallace H. Coulter Lifetime Achievement Award. Dr. Rai is the Joel Finkelstein Cancer Foundation Professor of Medicine, and Professor of Molecular Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell School of Medicine and Professor of Medicine at the Feinstein Institute for Medical Research, Manhasset, NY. Dr. Rai is rated as a Distinguished provider by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). His top areas of expertise are Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Leukemia, and Richter Syndrome.
Trustees Of Columbia University In The City Of New York
Nicole Lamanna is an Oncologist and a Hematologist in New York, New York. Dr. Lamanna is rated as an Elite provider by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). Her top areas of expertise are Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Bone Marrow Aspiration, and Gastrostomy.
Yale University
Scott Huntington is a Hematologist Oncology specialist and an Oncologist in New Haven, Connecticut. Dr. Huntington has been practicing medicine for over 16 years and is rated as a Distinguished provider by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). His top areas of expertise are Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Non-Hodgkin Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Multiple MyelomaDr. Parker isDistinguished. Learn about Multiple Myeloma.
- Schnitzler SyndromeDr. Parker isDistinguished. Learn about Schnitzler Syndrome.
- Smoldering Multiple MyelomaDr. Parker isDistinguished. Learn about Smoldering Multiple Myeloma.
- Advanced
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Parker isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- Chronic B-Cell Leukemia (CBCL)Dr. Parker isAdvanced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)
- Papular MucinosisDr. Parker isAdvanced. Learn about Papular Mucinosis.
- Primary AmyloidosisDr. Parker isAdvanced. Learn about Primary Amyloidosis.
- Experienced
- 2q37 Deletion SyndromeDr. Parker isExperienced. Learn about 2q37 Deletion Syndrome.
- 47 XYY SyndromeDr. Parker isExperienced. Learn about 47 XYY Syndrome.
- Aase SyndromeDr. Parker isExperienced. Learn about Aase Syndrome.
- Abruzzo-Erickson SyndromeDr. Parker isExperienced. Learn about Abruzzo-Erickson Syndrome.
- Acrodermatitis EnteropathicaDr. Parker isExperienced. Learn about Acrodermatitis Enteropathica.
- Acrorenal Mandibular SyndromeDr. Parker isExperienced. Learn about Acrorenal Mandibular Syndrome.
